Nanosonics Limited (ASX:NAN)
3.500
-0.180 (-4.89%)
Apr 28, 2026, 4:10 PM AEST
Nanosonics Market Cap
Nanosonics has a market cap or net worth of 1.1 billion as of April 28, 2026. Its market cap has decreased by -21.66% in one year.
Market Cap
1.10B
Enterprise Value
948.02M
Revenue
207.26M
Ranking
n/a
PE Ratio
55.34
Stock Price
3.50
Market Cap Chart
Since May 17, 2007, Nanosonics's market cap has increased from 151.14M to 1.10B, an increase of 628.57%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.10B | -8.56% |
| Dec 31, 2025 | 1.20B | 30.84% |
| Dec 31, 2024 | 920.45M | -30.92% |
| Dec 29, 2023 | 1.33B | 2.84% |
| Dec 30, 2022 | 1.30B | -31.96% |
| Dec 31, 2021 | 1.90B | -21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 62.31B |
| Sigma Healthcare | 32.09B |
| Pro Medicus | 14.45B |
| Sonic Healthcare | 10.04B |
| Neuren Pharmaceuticals | 1.56B |
| PYC Therapeutics | 1.27B |
| Clarity Pharmaceuticals | 1.09B |
| Integral Diagnostics | 830.65M |